PTJ
NUVA

Paul Tudor Jones’s NuVasive, Inc. NUVA Stock Holding History

Paul Tudor Jones’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,700
Closed -$222K – 3166
2021
Q3 		$222K Buy
+3,700
New +$228K ﹤0.01% 2245

Other funds holding NUVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Paul Tudor Jones's NUVA Position: Q2 2023 in Review

Paul Tudor Jones sold out of NuVasive, Inc. (NUVA) in Q2 2023, closing a stake of 8,393 shares — an estimated $347K sold.

Paul Tudor Jones first reported a position in NUVA in Q2 2013 and held it in 35 quarters. The position peaked at $5.37M in Q4 2014. 228 funds tracked by Wall St. Rank hold NUVA as of Q2 2023.

  • Paul Tudor Jones reported no remaining NuVasive, Inc. position as of Q2 2023 after selling out during the quarter.
  • Paul Tudor Jones sold 8,393 NuVasive, Inc. shares in Q2 2023, an estimated $347K.
  • Paul Tudor Jones first reported a position in NuVasive, Inc. in Q2 2013 and held it in 35 quarters.
  • Paul Tudor Jones's NuVasive, Inc. position peaked at $5.37M in Q4 2014.
  • 228 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.